This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings: Archive
Restaurant Brands Q2 Earnings Miss Estimates, Rise Y/Y, Stock Down
by Zacks Equity Research
QSR's Q2 earnings miss estimates but rise Y/Y, with sales growth led by Tim Hortons and International units.
BJRINegative Net Change CAKENegative Net Change LOCOPositive Net Change QSRNegative Net Change
earnings restaurants retail
Lamar Stock Falls Despite Q2 AFFO Beat, Revenues Increase Y/Y
by Zacks Equity Research
LAMR's Q2 results reflect growth in revenues. However, a higher component of expenses marred the performance to some extent.
PLDPositive Net Change CCINegative Net Change LAMRPositive Net Change
earnings finance reit
DBX Q2 Earnings Beat Estimates, Revenues Fall Y/Y, Shares Rise
by Zacks Equity Research
Dropbox tops Q2 earnings estimates with strong margins and cash flow, despite revenue and user declines from FormSwift pullback.
CSCOPositive Net Change VIPSNegative Net Change LITEPositive Net Change DBXPositive Net Change
artificial-intelligence earnings tech-stocks
Docebo Inc. (DCBO) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Docebo (DCBO) delivered earnings and revenue surprises of +45.00% and +2.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DCBOPositive Net Change INTAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for K12 (LRN) Stock
by Zacks Equity Research
K12 (LRN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
LRNPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why Holley (HLLY) Might be Well Poised for a Surge
by Zacks Equity Research
Holley Inc. (HLLY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
HLLYPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why InfuSystems Holdings (INFU) Might be Well Poised for a Surge
by Zacks Equity Research
InfuSystems Holdings, Inc. (INFU) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
INFUPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Rigel (RIGL): Time to Buy?
by Zacks Equity Research
Rigel Pharmaceuticals (RIGL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
RIGLNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Tree.com (TREE): Time to Buy?
by Zacks Equity Research
Tree.com (TREE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
TREENegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Starwood Property Shares Up on Q2 Earnings Beat, Expenses Decline Y/Y
by Zacks Equity Research
STWD stock rises 1.9% as Q2 earnings beat estimates, due to lower expenses despite revenue and BVPS declines.
STWDNegative Net Change ARINo Net Change NLYNegative Net Change
earnings finance
Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
INGN stock rises as Q2 loss narrows and revenue climbs 4% year over year, driven by strong B2B demand despite DTC and rental declines.
BSXNegative Net Change WSTPositive Net Change INGNNegative Net Change MEDPPositive Net Change
earnings medical medical-devices
PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises
by Zacks Equity Research
PACB stock jumps after Q2 results beat estimates, with narrow losses, rising margins, and strong global demand.
BSXNegative Net Change WSTPositive Net Change PACBPositive Net Change MEDPPositive Net Change
earnings medical medical-devices
Take-Two's Q1 Loss Narrows Year Over Year, Revenue Growth Continues
by Zacks Equity Research
TTWO rides strong engagement in NBA 2K25 and mobile, shrinking fiscal Q1 loss and posting 12.4% revenue growth.
TTWOPositive Net Change AMCNegative Net Change AFYAPositive Net Change ASPositive Net Change
consumer-discretionary earnings mobile tech-stocks
DASH Q2 Benefits From Strong Marketplace GOV: Time to Buy the Stock?
by Zacks Equity Research
DoorDash's second-quarter results benefit from surging Marketplace GOV, record order frequency, and expanding ad revenues.
CSCOPositive Net Change ADSKPositive Net Change AMATNegative Net Change DASHNegative Net Change
earnings tech-stocks
Brighthouse Financial Q2 Earnings Miss Estimates on Lower Premiums
by Zacks Equity Research
BHF posts Q2 earnings drop on lower premiums and investment income, despite a sharp cut in total expenses.
LNCNegative Net Change RGAPositive Net Change VOYANegative Net Change BHFNo Net Change
earnings finance insurance
Akamai Q2 Earnings Surpass Estimates, Revenues Increase Y/Y
by Zacks Equity Research
AKAM posts Q2 revenue and earnings beats on strong security and cloud demand across multiple end markets.
AKAMPositive Net Change JBLNegative Net Change MSIPositive Net Change UINegative Net Change
communications earnings tech-stocks
CBL Stock Rises Following Q2 Earnings and Mall Acquisitions
by Zacks Equity Research
CBL Properties' second-quarter 2025 results benefit from strong leasing gains and four major mall acquisitions, boosting cash flow and a higher dividend.
CBLPositive Net Change
earnings reit
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
by Zacks Equity Research
Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.
BSXNegative Net Change WSTPositive Net Change DOCSPositive Net Change GEHCPositive Net Change
earnings medical medical-devices
Microchip Q1 Earnings Beat Estimates, Sales Down Y/Y, Shares Drop
by Zacks Equity Research
MCHP's Q1 earnings and sales beat estimates despite steep yearly declines, with Q2 guidance signaling sequential growth ahead.
CSCOPositive Net Change MCHPNegative Net Change VIPSNegative Net Change LITEPositive Net Change
earnings semiconductor tech-stocks
AMN Stock Slips Despite Q2 Earnings & Revenue Beat, Margins Down
by Zacks Equity Research
AMN Healthcare tops second-quarter 2025 earnings and revenue forecasts, but margins and segment sales face continued pressure.
BSXNegative Net Change AMNNegative Net Change WSTPositive Net Change GEHCPositive Net Change
earnings medical medical-devices
Navitas Stock Declines 15.7% on Q2 Loss, Revenues Down Y/Y
by Zacks Equity Research
NVTS shares tumble after weak Q2 results and guidance, despite new NVIDIA and Powerchip deals targeting multi-billion-dollar markets by 2030.
CSCOPositive Net Change VIPSNegative Net Change LITEPositive Net Change NVTSNegative Net Change
artificial-intelligence earnings semiconductor tech-stocks
Nektar Q2 Loss Narrower Than Expected, Revenues Fall Y/Y
by Zacks Equity Research
NKTR's second-quarter top and bottom lines beat estimates. Studies on the lead candidate, rezpeg, are progressing well.
LLYNegative Net Change NKTRPositive Net Change CRMDPositive Net Change IMCRPositive Net Change
earnings medical
EnerSys' Q1 Earnings & Sales Beat Estimates, Increase Year Over Year
by Zacks Equity Research
ENS posts Q1 earnings and sales beats on data center, communications strength and Bren-Tronics boost; guides higher for Q2.
RBCPositive Net Change ITTPositive Net Change FSSPositive Net Change ENSPositive Net Change
earnings industrial-products
Expedia Q2 Earnings & Revenues Beat Estimates, Q3 Guidance Raised
by Zacks Equity Research
EXPE posts strong Q2 results with double-digit B2B growth, and boosts the Q3 and 2025 outlook for bookings, revenues and margins.
EXPENegative Net Change WSMNegative Net Change PFGCPositive Net Change WKSPPositive Net Change
earnings retail
Intellia Q2 Loss Narrower Than Expected, Pipeline Progress in Focus
by Zacks Equity Research
NTLA posts narrower Q2 loss and beats on revenues, while advancing phase III studies for ATTR and HAE programs.
REGNNegative Net Change CRMDPositive Net Change NTLAPositive Net Change IMCRPositive Net Change
biotechnology biotechs earnings gene-therapy medical pharmaceuticals